Alzheimer's disease
Atherosclerosis
The proprietor of this website is processing the personal data as a trustee for AFFiRiS AG, Karl-Farkas-Gasse 22, 1030 Vienna
Alzheimer's disease
Two Alzheimer vaccines are currently developed by AFFiRiS, AFFITOP AD01 and AFFITOP AD02. The second is now entering the second stage of clinical testing.
|
I consider participation in phase 2 study of AFFITOP AD02Atherosclerosis
In preparation